Latest Distributions News

Page 78 of 242
Nanoveu Limited’s transformative half-year report highlights its EMASS acquisition, executive hires, and technology advances amid a $3 million loss and new US OTCQB listing.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Excelsior Capital reported a sharp fall in net profit after tax for FY25 despite a 74% rise in investment income, reflecting the absence of last year’s one-off asset sale gain. The company declared a higher fully franked final dividend, signalling confidence in its portfolio.
Claire Turing
Claire Turing
29 Aug 2025
RLF AgTech Ltd has reported a remarkable financial turnaround in FY25, with revenues more than doubling and losses narrowing significantly, setting the stage for expansion in FY26.
Ada Torres
Ada Torres
29 Aug 2025
TasFoods reports a $3.6 million net loss for H1 2025, impacted by oversupply and discounted poultry prices, while advancing key initiatives including pet treats expansion and planned divestments.
Eva Park
Eva Park
29 Aug 2025
TasFoods narrowed its half-year loss by 29% despite a 21% drop in sales amid persistent poultry oversupply and discounted pricing. Strategic asset sales and cost-cutting efforts aim to stabilize the business in a challenging market.
Eva Park
Eva Park
29 Aug 2025
AIMS Property Securities Fund (APW) reported a remarkable financial year ending June 2025, with net income and revenue more than doubling and net tangible assets per unit rising 31.8%. The fund’s conservative, debt-free approach and diversified portfolio helped it outperform the broader market despite ongoing distribution suspensions.
Claire Turing
Claire Turing
29 Aug 2025
Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.
Ada Torres
Ada Torres
29 Aug 2025
Wellnex Life reported a strong 40.4% revenue increase to $23.6 million in FY25, alongside a 57% improvement in normalised EBITDA loss, signaling progress despite ongoing investment costs.
Ada Torres
Ada Torres
29 Aug 2025
Osteopore Limited reported a 6% increase in revenue to $1.56 million for the half-year ended June 2025, alongside a slight rise in net loss driven by expanded product development and compliance costs. The company secured key regulatory approvals and broadened its distribution footprint in Asia and the US.
Ada Torres
Ada Torres
29 Aug 2025
Finexia Financial Group has restated its FY24 financials due to a material error in expense accruals and reduced the value of its Stayco investment by $4 million following an external valuation review.
Claire Turing
Claire Turing
29 Aug 2025
NoviqTech Limited reported a $1.63 million loss for the half-year ending June 2025, while securing key partnerships and raising over $1 million to fuel its sustainability and blockchain innovation.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Pure Foods Tasmania reported a 30% revenue decline in FY25 but improved its net loss through cost-cutting and product rationalisation. Post-year-end recapitalisation efforts aim to strengthen the balance sheet and support the turnaround.
Victor Sage
Victor Sage
29 Aug 2025